News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Peraza Lisa
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 860 shares
@ $1.31, valued at
$1.1k
Exercised 552 restricted stock units
@ $0
Exercised 1,933 restricted stock units
@ $0 |
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 42,631 rights
@ $0 |
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 861 shares
@ $3.76, valued at
$3.2k
Exercised 553 restricted stock units
@ $0
Exercised 1,932 restricted stock units
@ $0 |
|
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2022 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 860 shares
@ $6.07, valued at
$5.2k
Exercised 552 restricted stock units
@ $0
Exercised 1,932 restricted stock units
@ $0 |
|
| 01/14/2022 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 966 shares
@ $8.3, valued at
$8k
Exercised 552 restricted stock units
@ $0
Exercised 1,933 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2020 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 103,000 options to buy
@ $15.72, valued at
$1.6M
Granted 8,833 restricted stock units
@ $0 |
|
| 10/15/2020 |
3
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/ |
|
|